Hologic, Inc. Announces Preliminary Revenue Guidance for the First Fiscal Quarter Ended December 30, 2017; Provides Effective Tax Rate Guidance for Fiscal 2018
January 08, 2018 at 12:03 pm
Share
Hologic, Inc. announced preliminary revenue guidance for the first fiscal quarter ended December 30, 2017. The company expects to report total revenues of approximately $791 million, an increase of almost 8% compared to the prior year period, and a 7% increase in constant currency. These preliminary results compare to the company's prior guidance range of $775 to $790 million.
The company expects its non-GAAP effective tax rate to be approximately 23% to 24% in fiscal 2018, lower than its prior guidance of approximately 31%. The company expects its GAAP effective tax rate to be negative for the year, largely based on the revaluation of its deferred taxes, but this analysis is ongoing.
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows:
- molecular diagnostics (46.7%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;
- breast health (35.5%): digital mammography and breast biopsy solutions and systems;
- gynecological surgery (15%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;
- bone health (2.8%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.
Net sales break down by source of revenue between sales of products (81.4%) and services (18.6%).
Net sales are distributed geographically as follows: the United States (75.9%), Europe (12.9%), Asia/Pacific (6.3%) and other (4.9%).
Hologic, Inc. Announces Preliminary Revenue Guidance for the First Fiscal Quarter Ended December 30, 2017; Provides Effective Tax Rate Guidance for Fiscal 2018
HOLOGIC, INC. 
